Covivio Hotels (COVH) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
15 Apr, 2026Executive summary
Real estate markets in Europe remain resilient with a comeback of large deals and positive momentum across offices, hotels, and German residential segments.
Strong operating performance with revenue up 4.8% at current scope and 3.5% like-for-like for the first nine months of 2025.
Occupancy rates remain high at 97.2%, reflecting robust demand and effective asset management.
Financial highlights
9M 2025 revenues reached €797.8m (100% share), up 4.8% at current scope and 3.5% like-for-like compared to 9M 2024.
Office segment revenue up 3.6% like-for-like; hotels up 1.5% like-for-like and 7.5% at current scope; German residential up 4.8% like-for-like.
Confirmed guidance for 2025 recurring net result (Adjusted EPRA Earnings) at €515m (+8% YoY) and €4.64/share (+4% YoY).
Outlook and guidance
Guidance for 2025 recurring net result and EPS confirmed, reflecting confidence in continued growth.
Positive medium-term outlook for hotels, with RevPAR expected to grow 4.4% in 2025 and 3.1% in 2026.
German residential segment expected to benefit from limited construction and rising rents.
Latest events from Covivio Hotels
- Revenue up 1.4% YoY, Milan hotel acquisition, and robust RevPAR drive positive outlook.COVH
Q1 2026 TU15 Apr 2026 - 2025 delivered strong earnings, higher hotel exposure, and robust Southern Europe performance.COVH
H2 202520 Feb 2026 - Revenue up 6.8% like-for-like, with strong hotel, office, and German residential growth.COVH
Q3 2024 TU3 Feb 2026 - Q1 2025 saw 5.4% revenue growth, high occupancy, and guidance confirmed at €495 million.COVH
Q1 2025 TU3 Feb 2026 - Balanced growth, ESG leadership, and city-center focus drive value and future opportunities.COVH
CMD 202412 Jan 2026 - Recurring net result up 14% and revenue up 9% in H1 2025, with net income at €341.4 million.COVH
H1 20256 Jan 2026 - Recurring net result and revenue rose sharply in 2024, with improved leverage and strong outlook.COVH
H2 20245 Jun 2025